These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7201812)

  • 1. [Investigations to gastric tolerance of a sustained release theophylline formulation (author's transl)].
    Lücker PW; Kraus M; Brenner H; Kyrein HJ; Schnitker J
    Arzneimittelforschung; 1982; 32(4):409-13. PubMed ID: 7201812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioavailability of theophylline in a new oral sustained-release preparation (author's transl)].
    Schneider GF; Heese GU; Huber HJ; Janzen N; Jünger H; Moser C; Stanislaus F
    Arzneimittelforschung; 1981; 31(9):1489-97. PubMed ID: 7197962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric stimulus response: Euphylline, theophylline, ethylenediamine and Riopan: gastric transmural potential difference (GPD)].
    Bruhn R; Ganote DP; Lücker PW
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):581-3. PubMed ID: 6664160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative measurement of transmural gastric potential difference after administration of Euphyllin solution, theophylline solution, ethylenediamine dihydrochloride solution and Riopan, buffered theophylline].
    Ganote DP; Bruhn R; Lücker PW
    Methods Find Exp Clin Pharmacol; 1982; 4(8):601-10. PubMed ID: 7169849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
    Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of choline theophyllinate and theophylline gastric irritation utilizing gastric potential difference as a model.
    Kraus M; Lücker PW; Eldon MA
    Arzneimittelforschung; 1981; 31(9):1503-7. PubMed ID: 7197964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation.
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH; Schwabe L; Staib AH; Rietbrock N; Lassmann A; Molz KH; Schuppan D; Siebert-Weigel M; Voegele D
    Arzneimittelforschung; 1983; 33(3):446-52. PubMed ID: 6683521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of theophylline in sustained-release formulation in young asthmatics].
    Witschital K; Fuchs WS; Heese U; von Nieciecki A; Laicher A
    Arzneimittelforschung; 1998 May; 48(5A):593-6. PubMed ID: 9676351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M; Rondanelli R; Vidale E; Cristiani D
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacokinetics and biologic availability of a new theophylline sustained-release preparation].
    Brüller W; Fischer M; Tritthart W
    Arzneimittelforschung; 1985; 35(12):1854-9. PubMed ID: 4096745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
    Wangemann M; Retzow A; Vens-Cappell B
    Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on the influence of food on the absorption of theophylline from a controlled-release preparation.
    Pabst G; Weber W; Müller M; Barkworth MF
    Arzneimittelforschung; 1994 Mar; 44(3):333-7. PubMed ID: 8192698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.